Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs.

Lynch, Julie A

Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs. [electronic resource] - Clinical lung cancer 07 2017 - 401-409 p. digital

Publication Type: Journal Article

1938-0690

10.1016/j.cllc.2016.11.018 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--diagnosis
DNA Mutational Analysis--methods
ErbB Receptors--genetics
Erlotinib Hydrochloride--therapeutic use
Female
Guideline Adherence
Humans
Lung Neoplasms--diagnosis
Male
Middle Aged
Mutation--genetics
Survival Analysis
United States
United States Department of Veterans Affairs
Veterans
Young Adult